Kirby Institute

variant of SARS-CoV-2

Associate Professor Stuart Turville from UNSW Sydney and the Kirby Institute's Immunovirology and Pathogenesis Program explains how variants emerge, how they are detected and what we know about the B.1617 variant.

stuart turville

Associate Professor Stuart Turville from UNSW Sydney’s Kirby Institute leads a team that has developed genetically “supercharged” cells to quickly understand

kirby cells

In this video, watch how the SARS-CoV-2 virus takes over cells by ‘melting’ them into each other.

Vaccination centre

In the end, the best protection is mass vaccination and ensuring as many people as possible are fully vaccinated as quickly as possible.

kirby institute researchers in the lab

In this video, watch how the SARS-CoV-2 virus takes over cells by ‘melting’ them into each other.

Doctor holds bottle with COVID-19 vaccine in laboratory

Australian researchers have identified the immune response associated with protection from COVID-19 – a discovery that may help cut the time it takes to develop new vaccines.

graphic of virus and people wearing masks

Will new guidelines on how to protect front-line workers acknowledge the coronavirus can spread via the air we breathe? It's time they did.

Destruction of hepatitis C virus, 3D illustration. Conceptual image for hepatitis C treatment

Hepatitis C testing and treatment in prisons is key to reducing infections, a new study by the Kirby Institute has shown.

mRNA versus adenovirus vaccine

What is the difference between the mRNA vaccine and the adenovirus vaccine? Can the mRNA vaccine be tweaked when new variants develop?

Pages